Pfenex (PFNX) Priced

Developing a biosimilar version of Roche's Lucentis treatment for wet AMD.

Health Care - Biotechnology

IPO Performance
Latest Trade $7.10 0.00 (0.0%)
First Day Return -11.7%
Return from IPO 18.3%
 
Pfenex IPO News more
  • .
IPO Data
IPO File Date 06/05/2014
Offer Price $6.00
Price Range $8.00 - $8.00
Offer Shares (mm) 8.3
Deal Size ($mm) 50
 
IPO Data
IPO Date 07/23/2014
Offer Price $6.00
Price Range $8.00 - $8.00
Offer Shares (mm) 8.3
Deal Size ($mm) $50
 
Underwriters
more
Business Overview
Developing a biosimilar version of Roche's Lucentis treatment for wet AMD.
Developing a biosimilar version of Roche's Lucentis treatment for wet AMD.
more
Company Data
Headquarters San Diego, CA
Founded 2009
Employees 25
Website www.pfenex.com
 

Performance vs. IPO Index (IPOUSA)